Sorrento Therapeutics
(OTC) SRNE
Sorrento Therapeutics Financials at a Glance
Market Cap
$441.00K
Revenue (TTM)
$64.27M
Net Income (TTM)
-$549.21M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-0.14 (Low)
Dividend
$0.00
Beta (Volatility)
-0.14 (Low)
Price
$0.00
Volume
99,263
Open
$0.00
Price
$0.00
Volume
99,263
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.10
Estimated Earnings Date
Aug 18, 2026
Dividend
$0.00
Beta (Volatility)
-0.14 (Low)
Price
$0.00
Volume
99,263
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.10
Estimated Earnings Date
Aug 18, 2026
SRNE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sorrento Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
949
CEO
Henry H. Ji, PhD
Website
www.sorrentotherapeutics.comHeadquarters
San Diego, CA 92121, US
SRNE Financials
Key Financial Metrics (TTM)
Gross Margin
46.77%
Operating Margin
-802.55%
Net Income Margin
-911.60%
Return on Equity
-1904.94%
Return on Capital
-435.13%
Return on Assets
-121.15%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$441.00K
Shares Outstanding
551.28M
Volume
99.26K
Avg. Volume
495.83K
Financials (TTM)
Gross Profit
$28.64M
Operating Income
-$463.35M
EBITDA
-$527.87M
Operating Cash Flow
-$234.63M
Capital Expenditure
-$8.59M
Free Cash Flow
-$243.21M
Cash & ST Invst.
$80.64M
Total Debt
$207.60M
Sorrento Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.03M
+31.1%
Gross Profit
$6.57M
+14.2%
Gross Margin
43.74%
N/A
Market Cap
$441.00K
N/A
Market Cap/Employee
$464.70
N/A
Employees
949
N/A
Net Income
-$95.21M
+56.6%
EBITDA
-$99.48M
+53.5%
Quarterly Fundamentals
Total Cash
$80.64M
-39.6%
Total Debt
$207.60M
-4.8%
Accounts Receivable
$32.73M
+32.4%
Inventory
$9.65M
-53.4%
Long Term Debt
$74.19M
-55.7%
Short Term Debt
$133.41M
+163.0%
Return on Assets
-1.21%
N/A
Return on Invested Capital
-3.48%
N/A
Free Cash Flow
-$55.80M
+33.3%
Operating Cash Flow
-$55.66M
+31.3%